Soleno Therapeutics Inc (SLNO)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Anish Bhatnagar |
| Employees: | 30 |
| Web site: | soleno.life |
|
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA, 94065
650-213-8444
| |
| Date | Ratio |
|---|---|
| 2017-10-06 | 1:5 |
| 2022-08-26 | 1:15 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Soleno Therapeutics is a clinical-stage biopharmaceutical company. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name in May 2017.
Please log in first to see chart